ES2094837T3 - Metodo para inhibir la toxicidad pulmonar por oxigeno. - Google Patents
Metodo para inhibir la toxicidad pulmonar por oxigeno.Info
- Publication number
- ES2094837T3 ES2094837T3 ES92105035T ES92105035T ES2094837T3 ES 2094837 T3 ES2094837 T3 ES 2094837T3 ES 92105035 T ES92105035 T ES 92105035T ES 92105035 T ES92105035 T ES 92105035T ES 2094837 T3 ES2094837 T3 ES 2094837T3
- Authority
- ES
- Spain
- Prior art keywords
- oxygen toxicity
- inhibiting pulmonary
- pulmonary oxygen
- inhibiting
- toxicity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1777—Integrin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
METODO PARA INHIBIR LA TOXICIDAD DEL OXIGENO PULMONAR. UN METODO PARA INHIBIR LA TOXICIDAD DEL OXIGENO PULMONAR EN UN PACIENTE QUE NECESITE NIVELES ELEVADOS DE OXIGENO INHALADO, MEDIANTE LA ADMINISTRACION PROFILATICA DE CIERTAS MOLECULAS Y ANTICUERPOS DE ADHERENCIA AL MISMO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67987091A | 1991-04-03 | 1991-04-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2094837T3 true ES2094837T3 (es) | 1997-02-01 |
Family
ID=24728710
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92105035T Expired - Lifetime ES2094837T3 (es) | 1991-04-03 | 1992-03-24 | Metodo para inhibir la toxicidad pulmonar por oxigeno. |
Country Status (13)
Country | Link |
---|---|
US (1) | US5310551A (es) |
EP (1) | EP0507187B1 (es) |
JP (1) | JP3228548B2 (es) |
AT (1) | ATE145827T1 (es) |
AU (1) | AU655459B2 (es) |
CA (1) | CA2064604C (es) |
DE (1) | DE69215568T2 (es) |
DK (1) | DK0507187T3 (es) |
ES (1) | ES2094837T3 (es) |
GR (1) | GR3022578T3 (es) |
HK (1) | HK1003106A1 (es) |
NZ (1) | NZ242192A (es) |
ZA (1) | ZA922408B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5629287A (en) * | 1991-01-18 | 1997-05-13 | University College London | Depot formulations |
US5610148A (en) * | 1991-01-18 | 1997-03-11 | University College London | Macroscopically oriented cell adhesion protein for wound treatment |
GB9115364D0 (en) * | 1991-07-16 | 1991-08-28 | Wellcome Found | Antibody |
US5708141A (en) * | 1992-05-11 | 1998-01-13 | Corvas International, Inc. | Neutrophil inhibitors |
WO2019191128A1 (en) * | 2018-03-26 | 2019-10-03 | The United States Of America As Represented By The Secretary Of The Navy | Use of tiotropium bromide to prevent pulmonary oxygen toxicity |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5109123A (en) * | 1988-06-14 | 1992-04-28 | Dana Farber Cancer Institute | Alteration of ability of soluble CD4 fragments to bind HIV |
US5147637A (en) * | 1988-06-07 | 1992-09-15 | The Rockefeller University | Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma |
ES2035668T3 (es) * | 1989-03-09 | 1993-04-16 | Boehringer Ingelheim Pharmaceuticals Inc. | Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma. |
-
1992
- 1992-03-24 DK DK92105035.7T patent/DK0507187T3/da active
- 1992-03-24 DE DE69215568T patent/DE69215568T2/de not_active Expired - Lifetime
- 1992-03-24 EP EP92105035A patent/EP0507187B1/en not_active Expired - Lifetime
- 1992-03-24 ES ES92105035T patent/ES2094837T3/es not_active Expired - Lifetime
- 1992-03-24 AT AT92105035T patent/ATE145827T1/de active
- 1992-04-01 NZ NZ242192A patent/NZ242192A/en not_active IP Right Cessation
- 1992-04-01 CA CA002064604A patent/CA2064604C/en not_active Expired - Lifetime
- 1992-04-02 AU AU13986/92A patent/AU655459B2/en not_active Expired
- 1992-04-02 ZA ZA922408A patent/ZA922408B/xx unknown
- 1992-04-02 JP JP08084092A patent/JP3228548B2/ja not_active Expired - Lifetime
-
1993
- 1993-02-10 US US08/015,744 patent/US5310551A/en not_active Expired - Lifetime
-
1997
- 1997-02-19 GR GR960403603T patent/GR3022578T3/el unknown
-
1998
- 1998-03-16 HK HK98102152A patent/HK1003106A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK0507187T3 (da) | 1997-04-07 |
ATE145827T1 (de) | 1996-12-15 |
ZA922408B (en) | 1992-12-30 |
EP0507187B1 (en) | 1996-12-04 |
AU655459B2 (en) | 1994-12-22 |
DE69215568D1 (de) | 1997-01-16 |
US5310551A (en) | 1994-05-10 |
CA2064604A1 (en) | 1992-10-04 |
HK1003106A1 (en) | 1998-10-09 |
JPH05255103A (ja) | 1993-10-05 |
NZ242192A (en) | 1997-06-24 |
EP0507187A1 (en) | 1992-10-07 |
AU1398692A (en) | 1992-10-08 |
JP3228548B2 (ja) | 2001-11-12 |
DE69215568T2 (de) | 1997-05-15 |
GR3022578T3 (en) | 1997-05-31 |
CA2064604C (en) | 2007-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3868127D1 (de) | F-serien-prostaglandine. | |
TW263423B (es) | ||
NO2008010I1 (no) | Kombinasjon av efavirenz, emtricitabin og tenofovirdisoproks: 1 eller salter derav | |
DE69232480T2 (de) | Beatmungsgerät zur Erzeugung von kontinuierlichem positiven Atemwegdruck (CPAP) | |
EP0509019A4 (en) | Treatment of human retroviral infections with 2',3'-dideoxyinosine | |
DE69732049D1 (de) | Pharmazeutische zubereitungen, enthaltend salze von hyaluronsäure und lokalanästhetika | |
RS49577B (sr) | Formulacije analoga insulina | |
ATE234615T1 (de) | Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren | |
TR199701654T1 (xx) | 4-Fenilaminotiyazol t�revleri. | |
ATE221083T1 (de) | Glialmitogene faktoren, ihre herstellung und verwendung | |
DE69401972T2 (de) | Feste Arzneimitteldosierungsform und Methode zur Verminderung des Abriebs | |
ES2094837T3 (es) | Metodo para inhibir la toxicidad pulmonar por oxigeno. | |
DE59203456D1 (de) | Flüchtige Inhalationsnarkotika enthaltende Liposomen, ihre Herstellung und Verwendung. | |
DE59309355D1 (de) | Neue Phospholipidderivate | |
ATE148991T1 (de) | Nicotinamid-adenin-dinukleodid enthaltendes antidepressionsmittel | |
DK0458536T3 (da) | Terapeutisk middel til behandling og forebyggelse af åndedrætsbesværsyndrom hos voksne | |
IT1202500B (it) | Valvola fonatoria per laringectomizzati | |
SE9003704D0 (sv) | New selenophen derivatives, a preparation process of the samme and therapeutical compositions containing them | |
ITRM910617A0 (it) | Apparecchio per la lettura dell'ossigeno o di altro componente gassosonell'aria, in particolare per il rilevamento dell'inquinamento | |
SE8600748L (sv) | Anordning for luftkonditionering av inandningsluft for menniskor med luftvegsbesver, fremst astma | |
DE68902143D1 (de) | Mund-zu-mund-beatmungsmaske. | |
UA13064A (uk) | Спосіб лікуваhhя хроhічhого первинного гастродуодеhіту і виразкової хвороби |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 507187 Country of ref document: ES |